Technical Analysis for TOCA - Tocagen Inc.

Grade Last Price % Change Price Change
grade B 10.74 -0.56% -0.06
TOCA closed down 0.56 percent on Tuesday, March 19, 2019, on 45 percent of normal volume.

Trend Table & Recent Signals
ADX Long-Term Intermediate-Term Short-Term
Weak or Absent Up Up Up
See historical TOCA trend table...

Date Alert Name Type % Chg
Mar 19 20 DMA Resistance Bearish 0.00%
Mar 18 20 DMA Resistance Bearish -0.56%
Mar 18 50 DMA Support Bullish -0.56%
Mar 18 Crossed Above 200 DMA Bullish -0.56%
Mar 18 MACD Bullish Centerline Cross Bullish -0.56%
Mar 15 200 DMA Resistance Bearish 3.37%
Mar 15 MACD Bearish Centerline Cross Bearish 3.37%
Mar 15 50 DMA Support Bullish 3.37%
Mar 15 Outside Day Range Expansion 3.37%
Mar 15 Down 3 Days in a Row Weakness 3.37%

Older signals for TOCA ...

Free Daily (Stock) Chart Reading

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
Configure default chart indicators
Basic chart:

Profile
Tocagen Inc. (Tocagen) is a clinical-stage, cancer-selective gene therapy company. The Company is focused on developing product candidates designed to activate a patient’s immune system against their own cancer. Its cancer-selective gene therapy platform is built on retroviral replicating vectors (RRVs), which are designed to selectively deliver therapeutic genes into the deoxyribonucleic acid (DNA) of cancer cells. Its lead product candidates are vocimagene amiretrorepvec (Toca 511) and flucytosine extended release (Toca FC). Toca 511 is an investigational injectable retroviral replicating vector (RRV) that encodes a prodrug activator enzyme, cytosine deaminase (CD). Toca FC is an investigational extended-release version of 5-fluorocytosine (5-FC), a prodrug that is inactive as an anti-cancer drug. As of February, 2017, Tocagen has completed enrollment of the Phase II portion with 187 patients.
Biotechnology Cancer Life Sciences Biology Gene Therapy Applied Genetics
Is TOCA a Buy, Sell or Hold?
Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength
Summary: Counts: 3 bullish, 0 bearish and 2 neutral indicators. You may wish to incorporate that into your trading strategies.
Indicators
Indicator Value
52 Week High 15.8
52 Week Low 6.47
Average Volume 169,876
200-Day Moving Average 10.5187
50-Day Moving Average 10.3544
20-Day Moving Average 10.808
10-Day Moving Average 10.605
Average True Range 0.5739
ADX 12.98
+DI 21.5707
-DI 18.6757
Chandelier Exit (Long, 3 ATRs ) 10.2783
Chandelier Exit (Short, 3 ATRs ) 11.581699999999999
Upper Bollinger Band 11.5642
Lower Bollinger Band 10.0518
Percent B (%b) 0.46
BandWidth 13.993338
MACD Line 0.0128
MACD Signal Line 0.0756
MACD Histogram -0.0628
Fundamentals Value
Market Cap 212.75 Million
Num Shares 19.8 Million
EPS -6.18
Price-to-Earnings (P/E) Ratio -1.74
Price-to-Sales 4252.02
Price-to-Book 2.06
PEG Ratio 0.00
Dividend 0.00
Dividend Yield 0.00%
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 11.37
Resistance 3 (R3) 11.40 11.22 11.26
Resistance 2 (R2) 11.22 11.06 11.20 11.23
Resistance 1 (R1) 10.98 10.96 10.89 10.95 11.19
Pivot Point 10.80 10.80 10.75 10.78 10.80
Support 1 (S1) 10.56 10.64 10.47 10.53 10.29
Support 2 (S2) 10.38 10.54 10.37 10.25
Support 3 (S3) 10.14 10.38 10.22
Support 4 (S4) 10.11